Lv6
3060 积分 2023-03-15 加入
Cyclic Peptide Linker Design and Optimization by Molecular Dynamics Simulations
2天前
已完结
Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development
2天前
已完结
Recent Advances in Scaffold Hopping
2天前
已完结
Exploiting Bridged Conformations for Precise Molecular Recognition in the Design of KRAS-Selective, Orally Available Macrocyclic Peptides
3天前
已完结
The effect of peptide size on target affinity in mRNA display-derived macrocyclic peptides
14天前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
15天前
已完结
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
16天前
已完结
Structure and dynamics of the CGRP receptor in apo and peptide-bound forms
25天前
已完结
Macrocyclic peptides as protein-protein interaction modulators: a review
1个月前
已完结
The effect of peptide size on target affinity in mRNA display-derived macrocyclic peptides
1个月前
已完结
皖公网安备34019202002308
